Marinomed Biotech AG (VIE:MARI)
Austria
· Delayed Price · Currency is EUR 12.15
-0.25 (-2.02%)
May 13, 2025, 5:37 PM CET
Marinomed Biotech AG Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 1.71 | 2.56 | 8.18 | 5.8 | 9.21 | Upgrade
|
| Cash & Short-Term Investments | 1.71 | 2.56 | 8.18 | 5.8 | 9.21 | Upgrade
|
| Cash Growth | -33.45% | -68.64% | 40.90% | -36.98% | -23.40% | Upgrade
|
| Accounts Receivable | 0.42 | 1.78 | 1.39 | 3.4 | 2.33 | Upgrade
|
| Other Receivables | 0.49 | 0.98 | 1.73 | 1.41 | 2.85 | Upgrade
|
| Receivables | 0.91 | 2.76 | 3.12 | 4.81 | 5.18 | Upgrade
|
| Inventory | 0.54 | 0.89 | 1.56 | 1.03 | 0.93 | Upgrade
|
| Prepaid Expenses | - | - | 1.41 | 1.24 | 0.08 | Upgrade
|
| Other Current Assets | 0.04 | 0.17 | -0 | 0 | - | Upgrade
|
| Total Current Assets | 3.29 | 6.39 | 14.27 | 12.88 | 15.4 | Upgrade
|
| Property, Plant & Equipment | 4.79 | 5.81 | 6.2 | 6.43 | 3.07 | Upgrade
|
| Long-Term Investments | 0.02 | 0.04 | - | - | - | Upgrade
|
| Other Intangible Assets | 0.09 | 0.13 | 0.2 | 0.18 | 0.2 | Upgrade
|
| Long-Term Deferred Charges | - | - | 1.61 | 1.83 | 1.86 | Upgrade
|
| Other Long-Term Assets | - | - | 0.01 | 0.02 | 2.97 | Upgrade
|
| Total Assets | 8.18 | 12.36 | 22.29 | 21.34 | 23.5 | Upgrade
|
| Accounts Payable | 1.69 | 1.53 | 1.15 | 1.99 | 1.98 | Upgrade
|
| Accrued Expenses | 0.82 | 0.23 | 0.82 | 1.54 | 1.18 | Upgrade
|
| Current Portion of Long-Term Debt | 28.23 | 7.58 | 2.45 | 0.74 | 0.34 | Upgrade
|
| Current Portion of Leases | - | - | - | 0.02 | 0.01 | Upgrade
|
| Current Income Taxes Payable | 0.28 | 0.2 | - | - | - | Upgrade
|
| Current Unearned Revenue | - | - | 0.84 | 1.39 | 0.85 | Upgrade
|
| Other Current Liabilities | 0.47 | 0.08 | 0.7 | 0.34 | 1.25 | Upgrade
|
| Total Current Liabilities | 31.49 | 9.62 | 5.96 | 6.01 | 5.61 | Upgrade
|
| Long-Term Debt | 1.04 | 14 | 20.18 | 15.01 | 12.44 | Upgrade
|
| Long-Term Leases | - | - | - | 0.04 | 0.02 | Upgrade
|
| Long-Term Unearned Revenue | 0.24 | 0.27 | 0.3 | 0.09 | 0.08 | Upgrade
|
| Other Long-Term Liabilities | 1.57 | 1.07 | - | -0 | - | Upgrade
|
| Total Liabilities | 34.34 | 24.96 | 26.44 | 21.15 | 18.14 | Upgrade
|
| Common Stock | 1.78 | 1.52 | 1.51 | 1.48 | 1.47 | Upgrade
|
| Retained Earnings | -70.93 | -54.86 | -49.76 | -43.36 | -37.47 | Upgrade
|
| Comprehensive Income & Other | 43 | 40.74 | 44.09 | 42.07 | 41.35 | Upgrade
|
| Shareholders' Equity | -26.16 | -12.6 | -4.16 | 0.19 | 5.36 | Upgrade
|
| Total Liabilities & Equity | 8.18 | 12.36 | 22.29 | 21.34 | 23.5 | Upgrade
|
| Total Debt | 29.28 | 21.58 | 22.63 | 15.8 | 12.81 | Upgrade
|
| Net Cash (Debt) | -27.57 | -19.02 | -14.45 | -10 | -3.61 | Upgrade
|
| Net Cash Per Share | -15.50 | -12.53 | -9.64 | -6.77 | -2.45 | Upgrade
|
| Filing Date Shares Outstanding | 1.78 | 1.54 | 1.52 | 1.49 | 1.47 | Upgrade
|
| Total Common Shares Outstanding | 1.78 | 1.52 | 1.51 | 1.48 | 1.47 | Upgrade
|
| Working Capital | -28.2 | -3.24 | 8.31 | 6.86 | 9.79 | Upgrade
|
| Book Value Per Share | -14.71 | -8.27 | -2.76 | 0.13 | 3.64 | Upgrade
|
| Tangible Book Value | -26.25 | -12.73 | -4.35 | 0.01 | 5.16 | Upgrade
|
| Tangible Book Value Per Share | -14.76 | -8.35 | -2.89 | 0.01 | 3.51 | Upgrade
|
| Land | 5.91 | 5.91 | 5.91 | 5.89 | 2.65 | Upgrade
|
| Machinery | 1.54 | 1.55 | 1.31 | 1.26 | 0.84 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.